News

The Initiator+ Alstra is useful for peptide chemists synthesizing peptides, peptoids, PNA and peptidomimetics, including complex modifications, for both small and large scale synthesis from 5µmol to 2mmol.

The agreement will allow the NHS trusts to select the electronic care records solutions of their choice and enable CSC to market the Lorenzo solution to NHS trusts

TIP is intended for use in CF patients aged six years and older whose lung function is within a certain range. The AIDAC approval was based on three

The validation solution, Globalvalidator, provides life sciences firms with capabilities such as viewing of envelope information, latest FDA validation sets, fast validation and Q+A36 best practice validation. The

Pennsaid is a topical non-steroidal anti-inflammatory drug (NSAID). Pennsaid 2%, which is not approved by the FDA, contains 2% diclofenac sodium compared to 1.5% for original Pennsaid. If

The open label study will assess the safety, tolerability and optimal dose of the antibody in up to 44 adult patients with malignant solid tumors and will even

Patheon chief executive officer James Mullen said that Patheon is happy to have reached an agreement with Bellwyck for the business. "While we don’t expect the terms of

Wockhardt has announced the immediate launch of Bupropion, the generic version of Glaxo Smithkline’s Wellbutrin SR, which it will manufacture at its facility in Waluj, India. The technology

Alvine is at present conducting Phase 2 trials with ALV003, an orally administered mixture of two recombinant gluten-specific proteases, a cysteine protease and a prolyl endopeptidase, in conjunction